https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4755-815d-99adf40ddc17
There have been a number of scenarios of Real World Evidence (RWE) that IMO support Mesoblast's decision to plan to run and additional COVID-19 ARDS Phase 3 trial using Remestemcel-L ... I thought we could use this thread to post them as we come across them ? Use the thread or don't use it; entirely up to you
An exponential increase in case numbers like this - 1,044,970 new cases in one day and USA hospitalisations up by 41% in two weeks would IMO support SI's reasons for undertaking an additional COVID-19 ARDS Phase 3 trial in the USA using our Remestemcel-L treatment.
https://www.nbcnews.com/news/us-new...-covid-cases-spread-omicron-variant-rcna10866
U.S. reaches 1 million daily Covid cases in spread of omicron variant
RWE for 2nd MSB COVID-19 ARDS P3 Trial
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.028(2.18%) |
Mkt cap ! $1.410B | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.30 | $1.23 | $7.561M | 5.972M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 12470 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 43061 | 16 |
View Market Depth
| Last trade - 14.25pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
-0.028 ( 4.06 %) |
||||
| Open | High | Low | Volume | ||
| $1.26 | $1.29 | $1.22 | 1226200 | ||
| Last updated 14.43pm 29/05/2024 ? | |||||
| MSB (ASX) Chart |